Back to Search
Start Over
Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial
- Source :
- Leukemia, 36(3):885888
- Publication Year :
- 2021
- Publisher :
- Springer Science and Business Media LLC, 2021.
- Subjects :
- Oncology
Isatuximab
Myeloma
Phase II trials
Cancer Research
medicine.medical_specialty
business.industry
Medizin
Front line
Hematology
medicine.disease
Interim analysis
Carfilzomib
chemistry.chemical_compound
chemistry
Internal medicine
medicine
business
Multiple myeloma
Dexamethasone
Lenalidomide
medicine.drug
Subjects
Details
- ISSN :
- 14765551 and 08876924
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Leukemia
- Accession number :
- edsair.doi.dedup.....c5867a89ed42a6cc58c40fadafddd147
- Full Text :
- https://doi.org/10.1038/s41375-021-01431-x